DM

DOMESCO Medical Import Export JSC

DMC · VN · Healthcare / Drug Manufacturers - Specialty & Generic

51,700.00VND-2300.00 (-4.26%)

Price History

Full chart

Market Stats

Previous Close54,000.00
Open52,000.00
Day Range51,700.00 – 52,000.00
52-Week Range52,150.86 – 60,284.48
Volume300
Market Cap1.90T
P/E (TTM)9.78
Forward P/E0.00
EPS5,606.04
Dividend Yield4.56%
Beta0.14
50-Day Avg57,860.00
200-Day Avg59,081.00

About

Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam. The company is also involved in the import and export of medicines, medicine materials, food-functional food, medical supplies, and medical equipment. It provides herbal, food, dietary supplement, and anti-epidermic products, as well as synthetic drug products such as, cardiovascular agents; antidiabetics; antibiotics; analgesics and antipyretic drugs; respiratory agents; gastrointestinal drugs; minerals and vitamins; and other synthetic drug products. The company offers its products under the Domesco brand name. The company was founded in 1989 and is headquartered in Cao Lãnh, Vietnam. Domesco Medical Import - Export Joint-Stock Corporation is a subsidiary of Abbott Laboratories(Chile) Holdco SpA.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Giang Thi Huong Luong
  • Employees912
  • HeadquartersNo. 346, Nguyen Hue Street, Cao Lanh, Vietnam, Vietnam
  • Websitehttps://www.domesco.com

Leadership

  • Ms. Giang Thi Huong LuongCEO, Vice Chairwoman, General Director & Member of Management Board · b. 1967
  • Mr. Tung Duy NguyenCFO & Deputy General Director · b. 1969
  • Ms. Tuyen Ngoc PhamChief Accountant · b. 1969

Financials

Income Statement

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.47T1.45T1.50T1.59T1.72T1.90T2.07T
Growth (%)--1.12%+3.20%+6.30%+7.93%+10.49%+8.84%
Cost of Revenue975.66B1.01T1.10T1.14T1.35T1.48T1.66T
Gross Profit492.73B438.47B401.62B452.89B372.10B417.48B409.11B
Gross Margin33.56%30.20%26.80%28.43%21.65%21.98%19.79%
Operating Expense225.79B235.29B215.21B218.41B188.66B191.45B188.31B
Operating Income266.95B203.18B186.40B234.48B183.44B226.03B220.80B
Operating Margin18.18%13.99%12.44%14.72%10.67%11.90%10.68%
EBITDA321.27B253.30B226.11B275.11B248.17B270.78B267.61B
EBITDA Margin21.88%17.45%15.09%17.27%14.44%14.26%12.94%
Net Income232.63B179.54B159.28B200.08B183.33B202.71B198.40B
Net Income Margin15.84%12.37%10.63%12.56%10.66%10.67%9.60%
Interest Expense1.80B2.89B2.76B5.21B5.07M514.26K93.03M
Interest Expense % of Total Revenue0.12%0.20%0.18%0.33%0.00%0.00%0.00%

Balance Sheet

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.53T1.46T1.62T1.84T1.85T1.84T1.92T
Total Liabilities280.78B148.61B255.82B378.47B328.65B228.05B227.56B
Total Equity1.25T1.32T1.37T1.46T1.52T1.61T1.69T
Cash98.37B107.53B85.38B47.46B114.33B129.73B75.84B

Cash Flow

Currency: VND2009-12-312014-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--111.07B-44.82B162.45B273.69B163.82B15.69B161.35B
Investing Cash Flow--18.10B140.80B-97.76B-224.78B---
Financing Cash Flow---110.32B-86.82B-86.82B-86.82B---
Capital Expenditure0035.20B14.26B6.11B10.57B7.39B41.61B36.70B
Free Cash Flow--75.87B-59.08B156.33B263.12B156.43B-25.93B124.66B
Dividends Paid--86.82B86.82B86.82B86.82B86.82B86.82B86.82B
FCF to OCF--68.31%131.81%96.24%96.14%95.49%-165.26%77.26%
Dividend Paid to FCF--114.43%-146.96%55.54%33.00%55.50%-334.88%69.65%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------
EPS Actual473.04839.26708.09641.08513.00762.79734.54343.69569.41654.93730.62643.35693.29715.46750.11937.17865.53992.80891.151069.69792.971143.67958.011213.481013.651321.411342.911179.181381.901693.881471.571432.411500.431597.241593.491869.971438.611664.471692.141903.651227.631881.12778.451301.06684.321221.191118.061564.09904.211398.351414.992043.77950.521373.77743.261414.821002.561499.79400.461881.711151.10776.22683.192631.281295.501383.69
Surprise------------------------------------------------------------------
Timing------------------------------------------------------------------

Key Statistics & Ratios

Market Cap1.90T
Enterprise Value1.55T
Trailing P/E9.78
Forward P/E0.00
Price / Sales0.89
Price / Book1.15
EPS5,606.04
Book Value48,250.66
Revenue (TTM)2.13T
Gross Profit (TTM)435.74B
EBITDA271.93B
Profit Margin10.77%
Operating Margin11.72%
Return on Equity14.13%
Return on Assets8.22%
Shares Outstanding34.73M
Shares Float0
Beta0.14
Dividend Yield4.56%
Dividend Rate2,500.00
Payout Ratio41.71%

Dividends

20261×
2500.00Sep 14, 2026
20251×
2500.00Sep 11, 2025
20241×
2500.00Sep 13, 2024
20231×
2500.00Sep 21, 2023
20221×
2500.00Sep 14, 2022
20211×
2500.00Oct 25, 2021
20201×
2500.00Oct 8, 2020
20191×
2500.00Sep 9, 2019
20181×
1000.00Aug 21, 2018
20172×
1500.00Dec 27, 20172000.00Jul 13, 2017
20161×
1538.46May 31, 2016
20152×
769.23Sep 9, 2015615.38Mar 4, 2015
20141×
538.46Jul 28, 2014
20132×
769.23Nov 12, 2013358.97May 7, 2013
20123×
769.23Nov 22, 2012615.39Jun 25, 2012512.82Jan 10, 2012
20112×
615.39Jun 20, 2011512.82Feb 23, 2011
20101×
512.82Jun 10, 2010
20091×
512.82Aug 24, 2009

Stock Splits

  • Jun 16, 201613:10
  • Jan 17, 20143:2
  • Aug 24, 200913:10